Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Br J Dermatol ; 181(3): 512-522, 2019 09.
Artículo en Inglés | MEDLINE | ID: mdl-30693469

RESUMEN

BACKGROUND: Recessive dystrophic epidermolysis bullosa (RDEB), Kindler syndrome (KS) and xeroderma pigmentosum complementation group C (XPC) are three cancer-prone genodermatoses whose causal genetic mutations cannot fully explain, on their own, the array of associated phenotypic manifestations. Recent evidence highlights the role of the stromal microenvironment in the pathology of these disorders. OBJECTIVES: To investigate, by means of comparative gene expression analysis, the role played by dermal fibroblasts in the pathogenesis of RDEB, KS and XPC. METHODS: We conducted RNA-Seq analysis, which included a thorough examination of the differentially expressed genes, a functional enrichment analysis and a description of affected signalling circuits. Transcriptomic data were validated at the protein level in cell cultures, serum samples and skin biopsies. RESULTS: Interdisease comparisons against control fibroblasts revealed a unifying signature of 186 differentially expressed genes and four signalling pathways in the three genodermatoses. Remarkably, some of the uncovered expression changes suggest a synthetic fibroblast phenotype characterized by the aberrant expression of extracellular matrix (ECM) proteins. Western blot and immunofluorescence in situ analyses validated the RNA-Seq data. In addition, enzyme-linked immunosorbent assay revealed increased circulating levels of periostin in patients with RDEB. CONCLUSIONS: Our results suggest that the different causal genetic defects converge into common changes in gene expression, possibly due to injury-sensitive events. These, in turn, trigger a cascade of reactions involving abnormal ECM deposition and underexpression of antioxidant enzymes. The elucidated expression signature provides new potential biomarkers and common therapeutic targets in RDEB, XPC and KS. What's already known about this topic? Recessive dystrophic epidermolysis bullosa (RDEB), Kindler syndrome (KS) and xeroderma pigmentosum complementation group C (XPC) are three genodermatoses with high predisposition to cancer development. Although their causal genetic mutations mainly affect epithelia, the dermal microenvironment likely contributes to the physiopathology of these disorders. What does this study add? We disclose a large overlapping transcription profile between XPC, KS and RDEB fibroblasts that points towards an activated phenotype with high matrix-synthetic capacity. This common signature seems to be independent of the primary causal deficiency, but reflects an underlying derangement of the extracellular matrix via transforming growth factor-ß signalling activation and oxidative state imbalance. What is the translational message? This study broadens the current knowledge about the pathology of these diseases and highlights new targets and biomarkers for effective therapeutic intervention. It is suggested that high levels of circulating periostin could represent a potential biomarker in RDEB.


Asunto(s)
Vesícula/patología , Epidermólisis Ampollosa Distrófica/patología , Epidermólisis Ampollosa/patología , Matriz Extracelular/patología , Fibroblastos/patología , Enfermedades Periodontales/patología , Trastornos por Fotosensibilidad/patología , Piel/patología , Xerodermia Pigmentosa/patología , Adolescente , Adulto , Biopsia , Vesícula/genética , Estudios de Casos y Controles , Células Cultivadas , Niño , Preescolar , Epidermólisis Ampollosa/genética , Epidermólisis Ampollosa Distrófica/genética , Proteínas de la Matriz Extracelular/metabolismo , Femenino , Fibrosis , Regulación de la Expresión Génica , Voluntarios Sanos , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Mutación , Enfermedades Periodontales/genética , Trastornos por Fotosensibilidad/genética , Cultivo Primario de Células , RNA-Seq , Piel/citología , Xerodermia Pigmentosa/genética , Adulto Joven
2.
Actas Dermosifiliogr ; 103(1): 5-11, 2012.
Artículo en Español | MEDLINE | ID: mdl-21596361

RESUMEN

Regenerative Medicine is an emerging field that combines basic research and clinical observations in order to identify the elements required to replace damaged tissues and organs in vivo and to stimulate the body's intrinsic regenerative capacity. Great benefits are expected in this field as researchers take advantage of the potential regenerative properties of both embryonic and adult stem cells, and more recently, of induced pluripotent stem cells. Bioengineered skin emerged mainly in response to a critical need for early permanent coverage of extensive burns. Later this technology was also applied to the treatment of chronic ulcers. Our group has established a humanized mouse model of skin grafting that involves the use of bioengineered human skin in immunodeficient mice. This model is suitable for the study of physiologic and pathologic cutaneous processes and the evaluation of treatment strategies for skin diseases, including protocols for gene and cell therapy and tissue engineering.


Asunto(s)
Piel , Ingeniería de Tejidos/métodos , Animales , Humanos , Ratones , Modelos Animales
3.
Actas Dermosifiliogr ; 103(1): 5-11, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22464599

RESUMEN

Regenerative Medicine is an emerging field that combines basic research and clinical observations in order to identify the elements required to replace damaged tissues and organs in vivo and to stimulate the body's intrinsic regenerative capacity. Great benefits are expected in this field as researchers take advantage of the potential regenerative properties of both embryonic and adult stem cells, and more recently, of induced pluripotent stem cells. Bioengineered skin emerged mainly in response to a critical need for early permanent coverage of extensive burns. Later this technology was also applied to the treatment of chronic ulcers. Our group has established a humanized mouse model of skin grafting that involves the use of bioengineered human skin in immunodeficient mice. This model is suitable for the study of physiologic and pathologic cutaneous processes and the evaluation of treatment strategies for skin diseases, including protocols for gene and cell therapy and tissue engineering.


Asunto(s)
Bioingeniería , Piel Artificial , Células Madre Adultas/citología , Animales , Apósitos Biológicos , Quemaduras/terapia , Células Cultivadas/trasplante , Modelos Animales de Enfermedad , Células Epidérmicas , Epidermólisis Ampollosa/patología , Fibroblastos/citología , Fibroblastos/trasplante , Humanos , Queratinocitos/citología , Queratinocitos/trasplante , Ratones , Ratones Desnudos , Psoriasis/patología , Especificidad de la Especie , Células Madre/citología , Cicatrización de Heridas
4.
Arch Dermatol Res ; 305(6): 501-12, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23775225

RESUMEN

Diseases of the skin are amenable to RNAi-based therapies and targeting key components in the pathophysiology of psoriasis using RNAi may represent a successful new therapeutic strategy. We aimed to develop a straightforward and highly reproducible in vitro psoriasis model useful to study the effects of gene knockdown by RNAi and to identify new targets for topical RNAi therapeutics. We evaluated the use of keratinocytes derived from psoriatic plaques and normal human keratinocytes (NHKs). To induce a psoriatic phenotype in NHKs, combinations of pro-inflammatory cytokines (IL-1α, IL-17A, IL-6 and TNF-α) were tested. The model based on NHK met our needs of a reliable and predictive preclinical model, and this model was further selected for gene expression analyses, comprising a panel of 55 psoriasis-associated genes and five micro-RNAs (miRNAs). Gene silencing studies were conducted by using small interfering RNAs (siRNAs) and miRNA inhibitors directed against potential target genes such as CAMP and DEFB4 and miRNAs such as miR-203. We describe a robust and highly reproducible in vitro psoriasis model that recapitulates expression of a large panel of genes and miRNAs relevant to the pathogenesis of psoriasis. Furthermore, we show that our model is a powerful first step model system for testing and screening RNAi-based therapeutics.


Asunto(s)
Marcación de Gen/métodos , Terapia Genética/métodos , Queratinocitos/metabolismo , Psoriasis/terapia , Interferencia de ARN , ARN Interferente Pequeño/metabolismo , Estudios de Casos y Controles , Células Cultivadas , Citocinas/metabolismo , Perfilación de la Expresión Génica , Humanos , Mediadores de Inflamación/metabolismo , Queratinocitos/inmunología , Queratinocitos/patología , MicroARNs/metabolismo , Fenotipo , Psoriasis/genética , Psoriasis/inmunología , Psoriasis/metabolismo , Psoriasis/patología , Transfección
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA